Professor Outterson teaches health care law at Boston University, where he co-directs the Health Law Program. He serves as the founding Executive Director and Principal Investigator for CARB-X, an >$800M international public-private partnership to accelerate global antibacterial innovation. Key partners in CARB-X include the US Government (BARDA & NIAID), the Wellcome Trust, the German Federal Ministry of Education and Research (BMBF), the UK Government (GAMRIF), and the Bill & Melinda Gates Foundation.
Professor Outterson has published almost 100 articles and book chapters (available at Google Scholar) on health care law, with a focus on incentive problems with antimicrobial resistance, including push and pull incentives for antimicrobials. He served as a senior author on many key research reports and expert panels on antibiotic innovation. Professor Outterson was given the 2015 Leadership Award by the Alliance for the Prudent Use of Antibiotics for his research and advocacy work. He has spoken before Congressional committees, Parliamentary working groups, WHO, and state legislatures.